Skip to main content

MESA LABORATORIES INC /CO/

For the period ended Mar 31, 2026. Filed Jun 3, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Jun 3, 2026

MLAB$136.91+7.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Stockholders’ Equity

(In thousands, except share amounts)

Common Stock
Number of SharesAmount(Accumulated Deficit) Retained EarningsAOCI*Total
March 31, 20235,369,466$332,076$74,199$(12,795)$393,480
Vesting of restricted stock units and exercise of stock options30,418358--358
Tax withholding on restricted stock units(5,393)(728)--(728)
Dividends paid, $0.64 per share--(3,447)-(3,447)
Stock-based compensation expense-11,936--11,936
Foreign currency translation---(1,960)(1,960)
Net (loss)--(254,246)-(254,246)
March 31, 20245,394,491$343,642$(183,494)$(14,755)$145,393
Vesting of restricted stock units and exercise of stock options69,5262,644--2,644
Tax withholding on restricted stock units(8,596)(887)--(887)
Dividends paid, $0.64 per share--(3,468)-(3,468)
Stock-based compensation expense-13,142--13,142
Foreign currency translation---4,9804,980
Net (loss)--(1,974)-(1,974)
March 31, 20255,455,421$358,541$(188,936)$(9,775)$159,830
Vesting of restricted stock units80,825----
Tax withholding on restricted stock units(11,315)(1,061)--(1,061)
Dividends paid, $0.64 per share--(3,523)-(3,523)
Stock-based compensation expense-17,868--17,868
Foreign currency translation---6,4196,419
Net income--6,712-6,712
March 31, 20265,524,931$375,348$(185,747)$(3,356)$186,245

*Accumulated Other Comprehensive (Loss) Income.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.